The impact of changing nicotine replacement therapy licensing laws in the United Kingdom: findings from the International Tobacco Control Four Country Survey
Open accessAbstract
Aim To evaluate the impact of a new licence for some nicotine replacement therapy products (NRT) for cutting down to stop (CDTS) on changes in the pattern of NRT use. Design Quasi‐experimental design comparing changes in NRT use across two waves of a population‐based, replenished‐panel, telephone survey conducted before and after the introduction of new licensing laws in the United Kingdom with changes in NRT use in three comparison countries (Australia, Canada and United States) without a licensing change. Participants A total of 7386 and 7013 smokers and recent ex‐smokers participating in the 2004 and/or 2006/7 survey. Measurements Data were collected on demographic and smoking characteristics as well as NRT use and access. In order to account for interdependence resulting from some participants being present in both waves, generalized estimation equations with an exchangeable correlation matrix were used to assess within‐country changes and linear and logistic regressions to assess between‐country differences in adjusted analyses. Findings NRT use was more prevalent in the United Kingdom and increased across waves in all countries but no wave × country interaction was observed. There was no evidence that the licensing change increased the prevalence of CDTS or the use of NRT (irrespective of how it was accessed) for CDTS in the United Kingdom relative to comparison countries. There was also no evidence for a change in concurrent smoking and NRT use among smokers not attempting to stop in the United Kingdom relative to comparison countries. Conclusion The addition of the CDTS licence for some NRT products in the United Kingdom appears to have had very limited, if any, impact on NRT use in the first year after the licence change.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In many other countries (unlike in the UK) NRT is rarely provided for free on prescription.
“and in many other countries (unlike in the UK) it is rarely provided for free on prescription.81”
From Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study (2015) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,514 · see citing works
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721 · cited 1× · see citing works
“NRT reduces withdrawal symptoms and urges to smoke [2] and has been shown to roughly double a smoker’s chances of quitting successfully [3].”
BackgroundPredicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI
Kozlowski, L. T., Porter, C. Q., Orleans, C. T., Pope, M. A., & Heatherton, T. F. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90158-9 · Cited by 494 · see citing works
Methods of the International Tobacco Control (ITC) Four Country Survey
Thompson, M. E., Fong, G. T., Hammond, D. G., Boudreau, C., Driezen, P., Hyland, A. J., Borland, R., Cummings, K. M., Hastings, G., Siahpush, M., et al. (2006) · Tobacco Control · doi:10.1136/tc.2005.013870 · Cited by 340 · see citing works
Self-citationHajek, P., West, R., Foulds, J., Nilsson, F., Burrows, S., & Meadow, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.17.2033 · Cited by 255 · see citing works
Self-citationWennike, P., Danielsson, T., Landfeldt, B., Westin, Å., & Tønnesen, P. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00489.x · Cited by 163 · see citing works
Wang, D., Connock, M., Barton, P., Fry-Smith, A., Aveyard, P., & Moore, D. (2008) · Health Technology Assessment · doi:10.3310/hta12020 · Cited by 137 · see citing works
Molyneux, A. (2004) · BMJ · doi:10.1136/bmj.328.7437.454 · Cited by 100 · see citing works
Batra, A., Klingler, K., Landfeldt, B., Friederich, H., Westin, Å., & Danielsson, T. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.019 · Cited by 94 · see citing works
Impact of UK policy initiatives on use of medicines to aid smoking cessation
West, R., DiMarino, M. E., Gitchell, J., & McNeill, A. (2005) · Tobacco Control · doi:10.1136/tc.2004.008649 · Cited by 92 · see citing works
Self-citationRegulation of nicotine replacement therapies (NRT): a critique of current practice.
McNeill, A., Foulds, J., & Bates, C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961217575.x · Cited by 87 · see citing works
Self-citationA national strategy for smoking cessation treatment in England
McNeill, A. D., Raw, M., Whybrow, J., & Bailey, P. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01022.x · Cited by 82 · see citing works
Self-citationEfficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial
Rennard, S. I., Glover, E. D., Leischow, S. J., Daughton, D. M., Glover, P. N., Muramoto, M. L., Franzon, M., Danielsson, T., Landfeldt, B., & Westin, Å. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200600789916 · Cited by 72 · see citing works
Hammond, D. G., Reid, J. L., Driezen, P., Cummings, K. M., Borland, R., Fong, G. T., & McNeill, A. D. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02320.x · Cited by 58 · see citing works
Self-citationReduction of abstinence induced withdrawal and craving using nicotine replacement therapy
Shiffman, S., Ferguson, S., Gwaltney, C. J., Balabanis, M. H., & Shadel, W. G. (2006) · eCite Digital Repository (University of Tasmania) · doi:10.1007/s00213-005-0184-3 · Cited by 14 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [8]Kralikova E, Kozak J, Rasmussen T, Cort N The clinical benefits of NRT-supported smoking reduction. Nicotine Tob Res 2002; 4: 243.
Cited by
Sorted by citations
Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study
Dobbie, F., Hiscock, R., Leonardi-Bee, J., Murray, S., Shahab, L., Aveyard, P., Coleman, T., McEwen, A., McRobbie, H., Purves, R., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19950 · Cited by 79 · see citing works
Self-citationBeard, E., McNeill, A., Aveyard, P., Fidler, J., Michie, S., & West, R. (2013) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050007 · Cited by 56 · see citing works
Self-citationKostygina, G., England, L., & Ling, P. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303057 · Cited by 24 · see citing works
Characterization of long-term users of nicotine replacement therapy: evidence from a national survey
Silla, K., Beard, E., & Shahab, L. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu019 · Cited by 11 · see citing works
Self-citation
- Authors
- Shahab, L., Cummings, K. M., Hammond, D., Borland, R., West, R., & McNeill, A.
- Affiliations
- University College London (GB)
- Roswell Park Comprehensive Cancer Center (US)
- University of Waterloo (CA)
- Cancer Council Victoria (AU)
- University of Nottingham (GB)
- Corresponding author
- Shahab, Lion
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2009-07-13
- Volume
- 104
- Issue
- 8
- Pages
- 1420-1427
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- PMC
- PMC6621546
- OpenAlex
- W2158174076
- Cited by
- 19
- References
- 15
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 1
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Cancer Research UK
- Johnson and Johnson
- Economic and Social Research Council (ES/G007489/1)
- National Cancer Institute (P50CA111236)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
- Keywords
- nicotine replacement therapy, product licensing, smoking cessation, tobacco control, former smokers, United Kingdom, Australia, Canada, United States
- MeSH terms
- Smoking Prevention, Australia, Canada, Commerce, Cross-Sectional Studies, Cross-Cultural Comparison, Female, United Kingdom, Humans, Licensure, Male, Middle Aged, Nicotine, Smoking, United States, Health Behavior, Smoking Cessation, Nicotinic Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
